A full structural clearance for homo-PP injection was achieved on Thursday driven by substantial baseline concessions, while wider platform engagement softened amid a broader spot market downturn.
Strategic baseline price cuts unlocked targeted, need-based PP procurement on Thursday, though a comprehensive rejection of all PE grades underscores a deeply cautious domestic and export outlook.